Outcome of Leflunomide in the Treatment of Proliferative Lupus Nephritis Compared to Cyclophosphamide
Open Access
- 1 January 2021
- journal article
- Published by Scientific Research Publishing, Inc. in Journal of Biosciences and Medicines
- Vol. 09 (03), 64-76
- https://doi.org/10.4236/jbm.2021.93008
Abstract
Scientific Research Publishing is an academic publisher of open access journals. It also publishes academic books and conference proceedings. SCIRP currently has 100+ open access journals in the areas of Earth & Environmental Sciences, Medicine & Healthcare, Biomedical & Life Sciences, Computer Science & Communications, Chemistry & Materials Science, Engineering, Physics & Mathematics, Business & Economics and Social Sciences & Humanities.Keywords
This publication has 24 references indexed in Scilit:
- Lupus nephritis: A critical reviewAutoimmunity Reviews, 2012
- The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patientKidney International, 2012
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care & Research, 2012
- Lupus Nephritis: An Overview of Recent FindingsAutoimmune Diseases, 2012
- Updates on the Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2010
- Birth outcomes in women who have taken leflunomide during pregnancyArthritis & Rheumatism, 2010
- Biomarkers for Lupus Nephritis: A Critical AppraisalJournal of Biomedicine and Biotechnology, 2010
- Urinary Biomarkers in Lupus NephritisClinical Reviews in Allergy & Immunology, 2010
- Changes in the Incidence of Endstage Renal Disease Due to Lupus Nephritis in the United States, 1996–2004The Journal of Rheumatology, 2009
- EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritisAnnals Of The Rheumatic Diseases, 2004